Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
ProMIS Neurosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
| Security |
| Security |
| Fee |
| Amount |
| | Proposed |
| | Maximum |
| | Fee |
| | Amount |
|
Fees to Be Paid | | Equity | | Common Shares, no par value per | | 457(c) | | 56,514,784 | | $ | 1.30 | | $ | 73,469,219.20 | | $ | 0.00014760 | | $ | 10,844.06 | |
| | | | | | Total Offering Amounts | | | | | $ | 73,469,219.20 | | | | | $ | 10,844.06 | | ||
| | | | | | Total Fees Previously Paid | | | | | | | | | | | | — | | ||
| | | | | | Total Fee Offsets | | | | | | | | | | | | — | | ||
| | | | | | Net Fees Due | | | | | | | | | | | $ | 10,844.06 | |
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of the Registrant’s Common Shares that may be issued in connection with a stock dividend, stock split, recapitalization or similar transactions. |
(2) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457 under the Securities Act, based on the average of the high and low prices of the Common Shares on the Nasdaq Capital Market on August 26, 2024. |
(3) | Consists of 56,514,784 shares of Common Shares that may be sold by the selling stockholders named herein, including 46,757,115 shares that are issuable upon exercise of warrants. |